| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.0006 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |